Combination effect of oncolytic adenovirotherapy and TRAIL gene therapy in syngeneic murine breast cancer models.
about
TRAIL gene-armed oncolytic poxvirus and oxaliplatin can work synergistically against colorectal cancer.Intravenous administration of adenoviruses targeting transforming growth factor beta signaling inhibits established bone metastases in 4T1 mouse mammary tumor model in an immunocompetent syngeneic host.Anticancer activity of oncolytic adenovirus vector armed with IFN-alpha and ADP is enhanced by pharmacologically controlled expression of TRAILTargeted cancer gene therapy using a hypoxia inducible factor dependent oncolytic adenovirus armed with interleukin-4Combinatorial treatment with oncolytic adenovirus and helper-dependent adenovirus augments adenoviral cancer gene therapy.Potent antitumor activity of oncolytic adenovirus expressing Beclin-1 via induction of autophagic cell death in leukemiaAnalysis of adenovirus trans-complementation-mediated gene expression controlled by melanoma-specific TETP promoter in vitro.Genetic immunotherapy of lung cancer using conditionally replicating adenovirus and adenovirus-interferon-beta.E1A-expressing adenoviral E3B mutants act synergistically with chemotherapeutics in immunocompetent tumor models.Synergistic effect of bladder cancer-specific oncolytic adenovirus in combination with chemotherapy.Second-generation HIF-activated oncolytic adenoviruses with improved replication, oncolytic, and antitumor efficacy
P2860
Q35647212-419133C5-D79A-4B71-A78D-0280039AA15AQ36179390-011D1A26-580F-4A5F-A4B0-A745ADE10288Q36209190-F8324907-FA0A-418C-AD0B-C19B55B2B5BFQ36488714-4F672249-2C91-4D46-9AB2-BBE57ABFCAECQ36664224-88D42E1C-41C2-4801-91FA-C5BD35732304Q37132233-138BFF24-E34E-49AF-B3D9-F5FED884941AQ39673855-1F03AC6B-147C-4BBD-9576-13EE90EE19A2Q39778480-5AD62001-391B-49BC-99F2-D3943488EBDEQ40045957-35D9D582-CE04-477B-9337-937F5FAB8A26Q41145145-8102DB24-00AA-4646-A704-2D38710347D7Q42370561-F61662E7-6FF7-4B5B-9800-4CFDC5D59A3D
P2860
Combination effect of oncolytic adenovirotherapy and TRAIL gene therapy in syngeneic murine breast cancer models.
description
2006 nî lūn-bûn
@nan
2006 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2006 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
name
Combination effect of oncolyti ...... c murine breast cancer models.
@ast
Combination effect of oncolyti ...... c murine breast cancer models.
@en
Combination effect of oncolyti ...... c murine breast cancer models.
@nl
type
label
Combination effect of oncolyti ...... c murine breast cancer models.
@ast
Combination effect of oncolyti ...... c murine breast cancer models.
@en
Combination effect of oncolyti ...... c murine breast cancer models.
@nl
prefLabel
Combination effect of oncolyti ...... c murine breast cancer models.
@ast
Combination effect of oncolyti ...... c murine breast cancer models.
@en
Combination effect of oncolyti ...... c murine breast cancer models.
@nl
P2093
P2860
P356
P1433
P1476
Combination effect of oncolyti ...... c murine breast cancer models.
@en
P2093
C Stephens
F Teraishi
P2860
P2888
P356
10.1038/SJ.CGT.7700863
P577
2006-01-01T00:00:00Z